Collegium Pharmaceutical is a private company in the pharmaceuticals sector.
WebsitePharmakon Advisorsfirm and Boston Millennia Partnersfirm list it as a past investment.
WebsiteWebsiteitem page4 deals name it. The latest is a financing in Jul 2024.
WebsitelistingPharmakon Advisorsfirm also lists ARCHIMED and Esperion Therapeuticscompany and Idorsiacompany.
Website
Owners
2 owners
| Firm | Status | Source |
|---|---|---|
| Pharmakon Advisors · Investment adviser | Past · 2022 | Website |
Boston Millennia Partners · FirmCollegium Pharmaceutical, Inc. (Nasdaq GS: COLL) is a specialty pharmaceutical company developing and planning to commercialize | Listed | Websiteitem page |
Deals
first 2 of 4
| Date | Deal | Firms | Source |
|---|---|---|---|
| Jul 2024 | Financing | Pharmakon Advisors (buyer) | Websitelisting |
| Feb 2022 | Financing | Pharmakon Advisors (buyer) | Websitelisting |
Other companies its owners list
first 2 of 10
| Company | Owner | Status | Source |
|---|---|---|---|
| ARCHIMED and Esperion Therapeutics | Pharmakon Advisors | Current | Website |
| Arthrosurface | Boston Millennia Partners | Current | Websiteitem page |
8 more companies
Listed by Pharmakon Advisors and Boston Millennia Partners.
Sign up free to see the first 5, or become a member to see all 10.